title: Intervention with costimulatory pathways as a therapeutic approach for graft-versus-host disease.
abstract: Graft-versus-host disease (GVHD) is mediated by mature donor T cells contained in the hematopoietic stem cell graft. During the development of GVHD, signaling through a variety of costimulatory receptors plays an important role in allogeneic T cell responses. Even though delivery of costimulatory signals is a prerequisite for full activation of donor T cells in the phase of their interactions with host APCs, their involvement with GVHD might occur over multiple stages. Like many other aspects of GVHD, promise of therapeutic interventions with costimulatory pathways has been gleaned from preclinical models. In this review, I summarize some of the advances in roles of costimulatory molecules in GVHD pathophysiology and discuss preclinical approaches that warrant further exploration in the clinic, focusing on novel strategies to delete pathogenic T cells.
authors.affiliation: School of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea. bkwon@ulsan.ac.kr
authors.forename: Byungsuk
authors.initials: B
authors.lastname: Kwon
mesh_terms: D000818:Animals; D006086:Graft vs Host Disease / Q000276:immunology* / Q000378:metabolism / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D014181:Transplantation Immunology / Q000276:immunology; D014184:Transplantation, Homologous
references.citation: J Exp Med. 2005 Aug 1;202(3):445-55
references.pmid: 16061730
references.citation: J Exp Med. 2006 Apr 17;203(4):883-95
references.pmid: 16606670
references.citation: Blood. 2005 Mar 1;105(5):2206-13
references.pmid: 15522958
references.citation: Nat Med. 2002 Dec;8(12):1405-13
references.pmid: 12426559
references.citation: Nat Rev Drug Discov. 2010 Apr;9(4):325-38
references.pmid: 20305665
references.citation: J Exp Med. 2005 Jun 20;201(12):1925-35
references.pmid: 15967822
references.citation: Nat Rev Immunol. 2007 May;7(5):340-52
references.pmid: 17438575
references.citation: Blood. 2007 Jul 15;110(2):776-82
references.pmid: 17363737
references.citation: Blood. 2005 Apr 15;105(8):3372-80
references.pmid: 15618467
references.citation: J Clin Invest. 2007 Oct;117(10):3029-41
references.pmid: 17853940
references.citation: J Immunol. 1995 Aug 15;155(4):1757-66
references.pmid: 7636232
references.citation: J Immunol. 1996 Nov 1;157(9):4258-67
references.pmid: 8892665
references.citation: Blood. 1998 Oct 15;92(8):2963-70
references.pmid: 9763584
references.citation: J Immunol. 2006 Jun 15;176(12):7394-401
references.pmid: 16751384
references.citation: Nat Med. 2004 Oct;10(10):1088-94
references.pmid: 15448685
references.citation: N Engl J Med. 2006 Sep 7;355(10):1018-28
references.pmid: 16908486
references.citation: Am J Transplant. 2007 Dec;7(12):2683-92
references.pmid: 17924994
references.citation: Blood. 2002 Jun 15;99(12):4601-9
references.pmid: 12036894
references.citation: J Immunol. 2010 May 1;184(9):4770-8
references.pmid: 20351189
references.citation: J Immunol. 2006 May 1;176(9):5223-31
references.pmid: 16621987
references.citation: J Exp Med. 1999 Nov 15;190(10):1535-40
references.pmid: 10562327
references.citation: J Immunol. 1990 Jan 1;144(1):16-22
references.pmid: 2153162
references.citation: Nat Rev Immunol. 2009 Apr;9(4):271-85
references.pmid: 19319144
references.citation: J Clin Invest. 2002 Feb;109(4):549-57
references.pmid: 11854328
references.citation: Biol Blood Marrow Transplant. 2009 Mar;15(3):306-14
references.pmid: 19203721
references.citation: Trends Immunol. 2010 Jun;31(6):236-45
references.pmid: 20362509
references.citation: Blood. 1994 Jun 15;83(12):3815-25
references.pmid: 7515723
references.citation: Nat Med. 1999 Nov;5(11):1298-302
references.pmid: 10545997
references.citation: Immune Netw. 2009 Jun;9(3):84-9
references.pmid: 20107537
references.citation: J Clin Invest. 2003 May;111(10):1505-18
references.pmid: 12750400
references.citation: J Immunol. 2005 Oct 15;175(8):4897-903
references.pmid: 16210591
references.citation: J Immunol. 1997 Jan 1;158(1):29-39
references.pmid: 8977172
references.citation: Blood. 2010 Mar 11;115(10):1941-8
references.pmid: 20068221
references.citation: Immunol Rev. 2009 May;229(1):5-11
references.pmid: 19426211
references.citation: Immunology. 2004 Sep;113(1):89-98
references.pmid: 15312139
references.citation: J Immunol. 2009 Apr 1;182(7):4107-15
references.pmid: 19299708
references.citation: J Clin Invest. 2006 Apr;116(4):1025-36
references.pmid: 16528411
references.citation: Annu Rev Immunol. 2007;25:139-70
references.pmid: 17129175
references.citation: J Immunol. 1999 Apr 15;162(8):4373-6
references.pmid: 10201970
references.citation: Blood. 2005 Feb 1;105(3):1355-61
references.pmid: 15459004
references.citation: Immunol Rev. 2009 May;229(1):271-93
references.pmid: 19426228
references.citation: J Immunol. 2001 Nov 1;167(9):4981-6
references.pmid: 11673505
references.citation: Blood. 2005 Mar 1;105(5):2227-34
references.pmid: 15522961
references.citation: J Immunol. 2006 Jul 15;177(2):814-21
references.pmid: 16818735
references.citation: J Immunol. 2007 Oct 1;179(7):4307-12
references.pmid: 17878324
references.citation: J Immunol. 2001 Mar 1;166(5):3174-83
references.pmid: 11207270
references.citation: Blood. 2005 Nov 1;106(9):3285-92
references.pmid: 15956289
references.citation: J Immunol. 2002 Feb 1;168(3):1457-65
references.pmid: 11801689
references.citation: Blood. 2007 Jun 1;109(11):4882-9
references.pmid: 17244673
references.citation: Blood. 2007 Jan 1;109(1):365-73
references.pmid: 16931626
references.citation: J Immunol. 2008 Nov 15;181(10):7380-9
references.pmid: 18981161
references.citation: Nat Med. 1997 Jun;3(6):682-5
references.pmid: 9176498
references.citation: J Exp Med. 2004 Jul 19;200(2):149-57
references.pmid: 15249593
references.citation: Invest Ophthalmol Vis Sci. 2005 Feb;46(2):596-603
references.pmid: 15671287
references.citation: Clin Exp Allergy. 2006 Mar;36(3):377-85
references.pmid: 16499650
references.citation: J Immunol. 1998 May 1;160(9):4225-31
references.pmid: 9574523
references.citation: J Immunol. 2008 Jul 1;181(1):47-61
references.pmid: 18566369
references.citation: Transplantation. 2007 Mar 27;83(6):774-82
references.pmid: 17414712
references.citation: J Clin Invest. 2004 Jun;113(11):1624-30
references.pmid: 15173889
references.citation: Blood. 2003 May 1;101(9):3741-8
references.pmid: 12521997
references.citation: J Immunol. 2001 Nov 15;167(10):5741-8
references.pmid: 11698447
references.citation: J Clin Invest. 1994 Sep;94(3):1333-8
references.pmid: 7521888
references.citation: Nat Med. 2000 Jun;6(6):673-9
references.pmid: 10835684
references.citation: J Immunol. 2004 Aug 15;173(4):2428-34
references.pmid: 15294956
references.citation: Cancer Res. 2010 May 15;70(10):3945-54
references.pmid: 20406989
references.citation: Biol Blood Marrow Transplant. 2008 Apr;14(4):365-78
references.pmid: 18342778
references.citation: J Immunol. 2004 Sep 1;173(5):2933-41
references.pmid: 15322151
references.citation: J Immunol. 2003 Aug 1;171(3):1272-7
references.pmid: 12874215
references.citation: J Immunol. 2007 Dec 1;179(11):7295-304
references.pmid: 18025172
references.citation: J Clin Invest. 1998 Aug 1;102(3):473-82
references.pmid: 9691083